Idarubicin |
Idamycin |
Clinical Trial: Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
This study is currently recruiting patients.
|
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Interferon alfa may interfere with the growth of cancer cells. It is not yet known if chemotherapy is more effective with or without interferon alfa and/or stem cell or bone marrow transplantation in treating chronic myelogenous leukemia.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without biological therapy and/or stem cell transplantation.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| chronic phase chronic myelogenous leukemia Philadelphia chromosome positive chronic myelogenous leukemia Philadelphia chromosome negative chronic myelogenous leukemia childhood chronic myelogenous leukemia atypical chronic myeloid leukemia | Drug: busulfan Drug: cyclophosphamide Drug: cytarabine Drug: etoposide Drug: filgrastim Drug: hydroxyurea Drug: idarubicin Drug: interferon alfa Procedure: allogeneic bone marrow transplantation Procedure: biological response modifier therapy Procedure: bone marrow ablation with stem cell support Procedure: bone marrow transplantation Procedure: chemotherapy Procedure: colony-stimulating factor therapy Procedure: cytokine therapy Procedure: high-dose chemotherapy Procedure: interferon therapy Procedure: peripheral blood stem cell transplantation Procedure: radiation therapy | Phase III |
MedlinePlus related topics: Bone Marrow Diseases; Immune System and Disorders; Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood; Lymphatic Diseases
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Hydroxyurea Cytoreduction Followed By Interferon alfa Versus Allogeneic Stem Cell Transplantation Versus High-Dose Chemotherapy Followed By Autografting and Interferon alfa Maintenance in Patients With Chronic Phase Chronic Myelogenous Leukemia
OBJECTIVES:
- Compare survival in patients with chronic myelogenous leukemia in early chronic phase treated with allogeneic bone marrow transplantation vs drug treatment with or without autologous peripheral blood stem cell transplantation.
- Compare survival of patients with late-phase disease treated with high-dose cytarabine vs low-dose cytarabine followed by autografting and interferon alfa maintenance.
- Compare survival of patients not responding cytogenetically to treatment with continued interferon alfa vs hydroxyurea.
- Determine frequency, time-point, and duration of hematological and cytogenetic remissions and of Philadelphia chromosome-negative and/or BCR-ABL-positive cells on the various treatments.
- Correlate the quality of hematological and cytogenetic remissions with survival time in patients treated with these regimens.
- Compare the course of the terminal phase in patients treated with these regimens.
- Compare the toxic effects of these regimens in these patients.
- Determine the effect of prognostic criteria and normal or subnormal WBC on chronic phase duration and survival time in patients treated with these regimens.
- Compare the effect of early vs late high-dose therapy plus autografting on feasibility, toxicity, and survival times in these patients.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to eligibility for transplantation (yes vs no).
All patients undergo cytoreduction comprising hydroxyurea (HU) IV daily.
Patients who are ineligible for or refuse transplantation are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive interferon alfa (IFN) subcutaneously (SC) daily. After 2 weeks of IFN therapy, patients also receive low-dose cytarabine (ARA-C) SC once daily for 10-15 days each month. Patients who do not achieve cytogenetic remission within 12 months continue to receive HU.
- Arm II: Patients receive IFN SC daily. After 2 weeks of IFN therapy, patients also receive low-dose ARA-C SC daily for 10-15 days each month. Patients who do not achieve cytogenetic remission within 12 months continue to receive IFN therapy SC daily. Patients who are eligible for transplantation with a related donor undergo allogeneic bone marrow transplantation. Patients may receive HU or IFN prior to transplantation. Patients may also receive oral high-dose busulfan daily for 4 days with or without cyclophosphamide or cyclophosphamide with total body irradiation.
Patients who are eligible for transplantation but do not have a related donor undergo peripheral blood stem cell (PBSC) harvest and are randomized to 1 of 2 treatment arms.
- Arm III: Patients receive IFN and low-dose ARA-C as in arm I. Patients who accelerate on treatment may undergo autologous PBSC transplantation.
- Arm IV: Patients receive idarubicin IV, ARA-C IV over 2 hours, and etoposide IV on days 1-3. Patients then undergo leukapheresis. Beginning on day 8, patients receive filgrastim (G-CSF) SC daily until end of leukapheresis. Patients then receive oral high-dose busulfan daily for 4 consecutive days. The following day, patients undergo reinfusion of autologous PBSC. After blood count recovery, patients receive maintenance IFN 3 times weekly for 8 weeks and then daily. Patients are followed every 3 months for 3 years and then every 6 months thereafter.
PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study within 5 years.
Eligibility
Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Diagnosis of chronic myelogenous leukemia in chronic phase
- Previously untreated
- Patients negative for Philadelphia chromosome and BCR-ABL translocation must fulfill at least 1 of the following criteria:
- Impaired health status with reduced exercise tolerance
- Spleen-related symptoms in cases of splenomegaly
- Weight loss greater than 10% in 6 months
- Fever greater than 38.5 degrees C on 5 consecutive days
- Clinically relevant bone pain
- Leukocytosis greater than 5,000/mm^3
- Thrombocytosis greater than 100,000/mm^3
PATIENT CHARACTERISTICS: Age:
- Any age
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- See Disease Characteristics
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- No other concurrent malignancy that is likely to require treatment during study or that is likely to reduce life expectancy
- No severe concurrent disease or other cause that would preclude study
- Not pregnant
PRIOR CONCURRENT THERAPY: Biologic therapy:
- No prior interferon
Chemotherapy:
- No prior chemotherapy
Endocrine therapy:
- Not specified
Radiotherapy:
- No prior radiotherapy
Surgery:
- Not specified
Location and Contact Information
Czech Republic
Masaryk University Hospital, Brno, 62500, Czech Republic; Recruiting
Germany
Allgemeines Krankenhaus Altona, Hamburg, 22763, Germany; Recruiting
Allgemeines Krankenhaus Hagen, Hagen, D-58095, Germany; Recruiting
Barmbek General Hospital, Hamburg, D-22291, Germany; Recruiting
Bundeswehr Krakenhaus, Ulm, D-89070, Germany; Recruiting
Caritas - Krakenhaus Lebach, Lebach, 66822, Germany; Recruiting
Caritasklinik St. Theresia, Saarbrucken, D-66113, Germany; Recruiting
Charite - Campus Charite Mitte, Berlin, D-10117, Germany; Recruiting
Charite - Campus Virchow Klinikum, Berlin, D-13353, Germany; Recruiting
Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein, D-55743, Germany; Recruiting
Department of Medicine III, Erlangen, D-91054, Germany; Recruiting
Deutsche Klinik fuer Diagnostik, Wiesbaden, D-65191, Germany; Recruiting
Diakonissen - Krankenhaus, Karlsruhe-Rueppur, 76199, Germany; Recruiting
Diakonissen-Krankenhaus Stuttgart, Stuttgart, D-70176, Germany; Recruiting
DR Herbert - Nieper Krankenhaus Goslar, Goslar, 38642, Germany; Recruiting
Eberhard Karls Universitaet, Tuebingen, D-72076, Germany; Recruiting
Europahochhaus, Bochum, 44787, Germany; Recruiting
Evangelische Krankenhaus Hamm, Hamm, DOH-59063, Germany; Recruiting
Evangelisches Krankenhaus Essen Werden, ESSEN, D-45239, Germany; Recruiting
Facharzt Fuer Jnnere Medizin, Karlsruhe, 76135, Germany; Recruiting
Franziskus Hospital, Bietigheim, 74321, Germany; Recruiting
Gemeinschaftspraxis Brunoehler, Oberhausen, 46045, Germany; Recruiting
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, Ansbach, 91522, Germany; Recruiting
Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie, Giessen, 35392, Germany; Recruiting
Gemeinschaftspraxis Innere Medizin, Jena, D-07743, Germany; Recruiting
Gemeinschaftspraxis, Munich, 80331, Germany; Recruiting
Gemeinschaftspraxis, Niddatel-IIbenstadt, 61194, Germany; Recruiting
Gemeinschaftspraxis, Mannheim, D-68161, Germany; Recruiting
Gemeinschaftspraxis, Nuernberg, D-90402, Germany; Recruiting
Haematologie Und Internistische Onkologie, Hanau, 63450, Germany; Recruiting
Haematologisch Onkologische Praxis, Aachen, 52070, Germany; Recruiting
Haematologische / Onkologische Schwerpunktpraxis, Krefeld, 47798, Germany; Recruiting
Haematologische Praxis, Augsburg, 86150, Germany; Recruiting
Haematologische Praxis, Stuttgart, D-70173, Germany; Recruiting
Haematologisch-Onkologische Praxis Altona, Hamburg, D-22767, Germany; Recruiting
Haematologisch-Onkologische Schwerpunktpraxis, Berlin, 13357, Germany; Recruiting
Hans - Susemihl - Krankenhaus, Emden, 26721, Germany; Recruiting
Helios Klinikum Berlin, Berlin, 13122, Germany; Recruiting
Helios Klinikum Wuppertal, Wuppertal, D-42283, Germany; Recruiting
Hematologisch - Onkologische Praxis, Wuerselen, 52146, Germany; Recruiting
Hematologische Onkologische Praxis, Regensburg, 93047, Germany; Recruiting
Hematologische Praxis, Oldenburg, 26121, Germany; Recruiting
Hermann - Holthusen Institute for Radiotherapy, Hamburg, D-20099, Germany; Recruiting
II Medizinische Klinik, Fuerth, 90766, Germany; Recruiting
II. Medizinische Klinik, Aschaffenburg, RG 63739, Germany; Recruiting
III Medizinische Klinik Mannheim, Mannheim, D-68305, Germany; Recruiting
Internistiche Praxis, Erfurt, 99084, Germany; Recruiting
Jakobi Krankenhaus, Rheine, 48431, Germany; Recruiting
Kinderklinik Aachen, Aachen, 52074, Germany; Recruiting
Kinderklinik der Freier Universitaet Berlin, Berlin, D-14059, Germany; Recruiting
Klinik fuer Onkologie - Katharinenhospital Stuttgart, Stuttgart, D-70174, Germany; Recruiting
Klinik fuer Radioonkologie und Strahlentherapie, Goeppingen, 73035, Germany; Recruiting
Klinik Konstanz, Konstanz, 78461, Germany; Recruiting
Klinik und Poliklinik fuer Kinderheilkunde - Universitaetsklinikum Muenster, Muenster, D-48129, Germany; Recruiting
Kliniken St. Antonius, Wuppertal 2, D-42283, Germany; Recruiting
Klinikum Coburg, Coburg, 96450, Germany; Recruiting
Klinikum der Friedrich-Schiller Universitaet Jena, Jena, D-07740, Germany; Recruiting
Klinikum Der Hansestadt Stralsund - Klin. West, STRALSUND, D-18410, Germany; Recruiting
Klinikum der J.W. Goethe Universitaet, Frankfurt, D-60590, Germany; Recruiting
Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, D-67063, Germany; Recruiting
Klinikum Der Stadt Villingen - Schwenningen, Villingen-Schwenningen, D-78054, Germany; Recruiting
Klinikum der Universitaet Regensburg, Regensburg, D-93053, Germany; Recruiting
Klinikum Erfurt, Erfurt, 99089, Germany; Recruiting
Klinikum Garmisch - Partenkirchen, Garmisch-Partenkirchen, N 82467, Germany; Recruiting
Klinikum Grosshadern der Ludwig-Maximilians Universitaet Muenchen, Munich, D-81377, Germany; Recruiting
Klinikum Kassel, Kassel, D-34125, Germany; Recruiting
Klinikum Kempten Oberallgaeu, Kempten, 87439, Germany; Recruiting
Klinikum Krefeld GmbH, Krefeld, D-47805, Germany; Recruiting
Klinikum Lippe - Lemgo, LEMGO, D-32657, Germany; Recruiting
Klinikum Minden, Minden, D-32423, Germany; Recruiting
Klinikum Nuernberg - Klinikum Nord, Nuernberg, D-90419, Germany; Recruiting
Klinikum Nuernberg - Klinikum Sued, Nuernberg, D-90471, Germany; Recruiting
Klinikum Oldenburg, Oldenburg, D-26133, Germany; Recruiting
Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, D-81675, Germany; Recruiting
Klinikum Remscheid GMBH, Remscheid, 42859, Germany; Recruiting
Klinikum St. Marien, Amberg, D-92224, Germany; Recruiting
Krankenhaus Bietigheim, Bietigheim, 74321, Germany; Recruiting
Krankenhaus D Barmherzigen Brueder, Regensburg, 93049, Germany; Recruiting
Krankenhaus Dueren, Dueren, 52351, Germany; Recruiting
Krankenhaus Hohe Warte Mediziniche Klinik, Bayreuth, 95445, Germany; Recruiting
Krankenhaus Maria Hilf GmbH, Moenchengladbach, DOH-41063, Germany; Recruiting
Krankenhaus Muenchen Neuperlach, Munich, D-81737, Germany; Recruiting
Krankenhaus Muenchen Schwabing, Munich, 80804, Germany; Recruiting
Krankenhaus Neukoelln, Berlin, D-12313, Germany; Recruiting
Krankenhaus Siloah - Medizinische Klinik II, Hannover, D-30449, Germany; Recruiting
Krankenhaus St. Michael, Voeklingen, 66333, Germany; Recruiting
Kreiskrankenhaus Boeblingen, Boeblingen, 71032, Germany; Recruiting
Kreiskrankenhaus Fuessen, Fuessen, 87629, Germany; Recruiting
Kreiskrankenhaus Mellrichstadt, Mellrichstad, DT-97638, Germany; Recruiting
Kreiskrankenhaus Radebeul, Radebeul, D-01445, Germany; Recruiting
Kreiskrankenhaus Siegen, Siegen, D-57076, Germany; Recruiting
Kreiskrankenhaus, Waldroel, 51545, Germany; Recruiting
Kreiskrankenhaus, Aalen, 73430, Germany; Recruiting
Kreiskrankenhaus, Bad Hersfeld, 36251, Germany; Recruiting
Kreiskrankenhaus, Herford, D-32049, Germany; Recruiting
Luisenkrankenhaus, Lindenfels, 64678, Germany; Recruiting
Malteser Krankenhaus, Flensburg, D-24939, Germany; Recruiting
Marienhospital Bottrop, Bottrop, D-46236, Germany; Recruiting
Medizinische Hochschule Hannover, Hannover, D-30625, Germany; Recruiting
Medizinische Kl. Klinikum Innenstadt Universitaet Muenchen, Munich, D-80336, Germany; Recruiting
Medizinische Klinik Am Lukas - Krankenhaus, Buende, 32257, Germany; Recruiting
Medizinische Klinik I, Dresden, D-01307, Germany; Recruiting
Medizinische Poliklinik, Bonn, D-53111, Germany; Recruiting
Medizinische Universitaetsklinik I, Cologne, D-50924, Germany; Recruiting
Medizinische Universitaetsklinik und Poliklinik, Heidelberg, 69115, Germany; Recruiting
Michael Schaefers und Partner, Duisburg, D-47051, Germany; Recruiting
Mutterhaus der Borromaerinnen, Trier, D-54219, Germany; Recruiting
Onkolog - Haematolog Schwerpunktpraxis, Berlin, D-10559, Germany; Recruiting
Onkolog Gemeinschaftspraxis, Frankfurt, 60389, Germany; Recruiting
Onkologische Praxis Lueneburg, Lueneburg, D-21335, Germany; Recruiting
Onkologische Schwerpunkt Praxis, Erlangen, 91052, Germany; Recruiting
Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, D-33602, Germany; Recruiting
Onkologische Schwerpunktpraxis Leer, Leer, D-26789, Germany; Recruiting
Onkologische Schwerpunktpraxis, Cottbus, D-03046, Germany; Recruiting
Onkologischer Schwerpunkt Lerchenfeld, Hamburg, D-22081, Germany; Recruiting
Paracelsas Klinik Osnabrueck, Osnabrueck, D-49076, Germany; Recruiting
Philipps-Universitaet Marburg Klinikum, Marburg, D-35033, Germany; Recruiting
Praxis am Evangelischen Krankenhaus Bethanien, Iserlohn, D-58644, Germany; Recruiting
Praxis DR. J. Weniger, Erfurt, D-99085, Germany; Recruiting
Praxis Fuer Haematologie Internistische Onkologie, Koeln, D-50677, Germany; Recruiting
Praxis fuer Haematologie und Interne Onkologie, Norderstedt, 22844, Germany; Recruiting
Praxis Fuer Haematologie/Onkologie, Luebeck, 23560, Germany; Recruiting
Praxis Fuer Haemotologie Und Internistischer Onkologie, Wuppertal, 42105, Germany; Recruiting
Praxis fuer Innere Medizin und Haematologie, Munich, D-80797, Germany; Recruiting
Praxis Fuer Internistische Haematologie / Onkologie, Troisdorf, 53840, Germany; Recruiting
Praxis Gemeinschaft, Koeln, D-50676, Germany; Recruiting
Praxisgemeinschaft, Tuebingen, 72070, Germany; Recruiting
Prosper-Hospital Recklinghausen, Recklinghausen, D-45659, Germany; Recruiting
Trier, D-54290, Germany; Recruiting
Robert-Bosch-Krankenhaus, Stuttgart, 70376, Germany; Recruiting
Ruppiner Klinikum GMBH, Neuruppin, 16816, Germany; Recruiting
Saechsische Schweiz Klinik, Sebnitz, D-01855, Germany; Recruiting
Schwerpunktpraxis Fuer Haematologie Und Onkologie, Saarbruecke, N-66113, Germany; Recruiting
St Elisabeth Krankenhaus, Ravensburg, 88191, Germany; Recruiting
St Marienkrankenhaus, Ludwigshafen, Rhein, D-67067, Germany; Recruiting
St. Antonius Hospital, Eschweiler, DOH-52249, Germany; Recruiting
St. Hedwig Kranken Haus, Berlin, 10115, Germany; Recruiting
St. Irmgardis Krankenhaus, Viersen-Suechteln, 41749, Germany; Recruiting
St. Johannes Hospital - Medical Klinik II, Duisburg, D-47166, Germany; Recruiting
St. Joseph Hospital, Bremerhaven, N-27568, Germany; Recruiting
St. Marien - Krankenhaus Siegen GMBH, Siegen, D-57072, Germany; Recruiting
St. Marien Hospital at Katholisches Krankenhaus hagen gem. GmbH, Hagen, 58095, Germany; Recruiting
St. Marien-Hospital Hamm - Klinik Knappenstrasse, Hamm, D-59071, Germany; Recruiting
St. Willehad Hospital, Wilhelmshaven, D-26382, Germany; Recruiting
Stadt. KH Dresden - Neustadt, Dresden, 01129, Germany; Recruiting
Staedt Klinikum Karlsruhe GGMBH, Karlsruhe, 76133, Germany; Recruiting
Staedt Krankenhaus, Sebnitz, D-01855, Germany; Recruiting
Staedtisches Klinikum Braunschweig, Braunschweig, D-38114, Germany; Recruiting
Staedtisches Krankenhaus Muenchen - Harlaching, Munich, D-81545, Germany; Recruiting
Staedtisches Krankenhaus, Pforzheim, 75175, Germany; Recruiting
Tumorzentrum Berlin - Moabit e.V., Berlin, 10967, Germany; Recruiting
Universitaet Ulm, Ulm, D-89075, Germany; Recruiting
Universitaetklinikum Des Saarlandes, St. Ingbert, 66386, Germany; Recruiting
Universitaets - Kinderpoliklinik, Muenchen, 80336, Germany; Recruiting
Universitaetsklinik Duesseldorf, Duesseldorf, D-40225, Germany; Recruiting
Universitaetsklinikum Bonn, Bonn, D-53105, Germany; Recruiting
Universitaetsklinikum Essen, ESSEN, D-45122, Germany; Recruiting
Universitaetsklinikum Freiburg, Freiburg, D-79106, Germany; Recruiting
Universitaetsklinikum Goettingen, GOETTINGEN, D-37075, Germany; Recruiting
Universitaetsklinikum Ulm, Ulm, D-89081, Germany; Recruiting
Universitaets-Krankenhaus Eppendorf, Hamburg, D-20246, Germany; Recruiting
Universitatsklinik - Saarland, Homburg, D-66421, Germany; Recruiting
University Hospital Schleswig-Holstein - Kiel Campus, Kiel, D-24105, Germany; Recruiting
Urologische Klinik - Universitaetsklinikum Aachen, Aachen, D-52074, Germany; Recruiting
Urologische Klinik, Giessen, D-35392, Germany; Recruiting
Vincentius Krankenhaus, Karlsruhe, D-76137, Germany; Recruiting
Vinzentiuskrankenhaus, Landau, D-76829, Germany; Recruiting
Munich, 80637, Germany; Recruiting
Wenckebach - Krankenhaus, Berlin, 12099, Germany; Recruiting
Munich, D-81241, Germany; Recruiting
Zentralklinikum Augsburg, Augsburg, DOH-86156, Germany; Recruiting
Zentralkrankenhaus, Bremen, D-28205, Germany; Recruiting
Zentralkrankenhaus, Bremerhaven, N 27574, Germany; Recruiting
Poland
Medical University of Gdansk, Gdansk, 80-211, Poland; Recruiting
Silesian Medical Academy, Katowice, 40-029, Poland; Recruiting
Spain
Hospital Universitario "Virgen de la Victoria" Malaga, Malaga, 29010, Spain; Recruiting
Switzerland
Bezirksspital Dornach, Dornach, CH-4143, Switzerland; Recruiting
Centre Hospitalier Universitaire Vaudois, Lausanne, CH-1011, Switzerland; Recruiting
Facharzt FMH Fuer Innere Medizin and Oncology, Baar, CH-6340, Switzerland; Recruiting
Facharzt Fuer Onkologie-Hematologie, Bern, 3013, Switzerland; Recruiting
FMH f. Innere Medizin and Hematologie, Grosshochstetten, 3506, Switzerland; Recruiting
Hopital Cantonal Universitaire de Geneve, Geneva, CH-1211, Switzerland; Recruiting
Inneremedizin FMH, Breitenbach, 4226, Switzerland; Recruiting
Inselspital, Bern, Bern, CH-3010, Switzerland; Recruiting
Institut Central des Hopitaux Valaisans, Sion, CH1951, Switzerland; Recruiting
Kantonspital Aarau, AARAU, 5001, Switzerland; Recruiting
Kantonsspital - St. Gallen, St. Gallen, CH-9007, Switzerland; Recruiting
Kantonsspital, Luzerne, Luzerne, CH-6016, Switzerland; Recruiting
Klinik Hirslanden, Zurich, CH-8008, Switzerland; Recruiting
Oncology Institute of Southern Switzerland, Bellinzona, CH-6500, Switzerland; Recruiting
UniversitaetsSpital, Zurich, CH-8091, Switzerland; Recruiting
Universitatsspital-Basel, Basel, CH-4031, Switzerland; Recruiting
Basel, CH 4051, Switzerland; Recruiting
Ruediger Hehlmann, MD, Study Chair, III. Medizinische Klinik Mannheim
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: September 2003
Last Updated: April 4, 2005
Record first received: October 11, 2001
ClinicalTrials.gov Identifier: NCT00025402
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Idamycin (Drug Digest)
- Idarubicin (Drug Digest)

Not Signed In -


